Title: S Eathiraj, et al. Targeting PCI-32765-Resistant BTK-C481S Mutation with ARQ 531, a Reversible Non-Covalent Inhibitor of BTK. Clinical Lymphoma Myeloma & Leukemia, 2016, 16: S47-S48.
1018675-35-8 | CVT-12012 | AA01EO9U | MFCD18251587
2109805-75-4 | CU-CPT17e | AA01EOH3 | MFCD31692328
1449598-06-4 | RG7800 | AA01EON0 | MFCD31382130
157182-47-3 | N-(2R-hydroxypropyl)-5Z,8Z,11Z,14Z-eicosatetraenamide | AA01EOSE
1863065-90-0 | N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | AA01EP1J | MFCD30718093
112964-97-3 | N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)-4-piperidinyl]-acetamide,monohydrochloride | AA01EPC3 | MFCD30716866
120330-93-0 | N-[2-[(1R,2R)-3-oxo-2-(2Z)-2-penten-1-ylcyclopentyl]acetyl]-L-isoleucine,N-[2-[(1S,2S)-3-oxo-2-(2Z)-2-penten-1-ylcyclopentyl]acetyl]-L-isoleucine | AA01EPIK | MFCD18781917
1228664-49-0 | N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy-1,1,2,2,3,3-d6]-4-quinazolinamine | AA01EPO7
28456-18-0 | N-(2-methylphenyl)-1-(2-phenylethyl)-4-piperidinamine | AA01EPUG
151057-28-2 | N-[(1S)-2R-hydroxy-1-[[(3-O-sulfo-β-D-galactopyranosyl)oxy]methyl]-3E-heptadecen-1-yl]-15Z-tetracosenamide | AA01EQ3K